呼吸系統疾病

互動

閱讀原文引述

我們就藥品福利諮詢委員會 [PBAC] 對哮喘相關藥物（包括部分疫苗）的報銷事宜提供公眾意見。

We provide public comment to the Pharmaceutical Benefits Advisory Committee for the reimbursement of medicines relating to asthma, including some vaccines. We write and support submissions to the Therapeutic Goods Administration for changes to medicines. Asthma Australia will lobby government if a change that is made is not in the best interest of people with asthma.

互動

閱讀原文引述

患者群體證據提交至加拿大藥物局（CADTH [加拿大藥物與健康技術局]、INESSS [國家健康及社會服務卓越研究院] 及 BC [不列顛哥倫比亞省] Pharmacare）。

Patient Group Evidence submissions to Canada's Drug Agency (CADTH), INESSS and BC Pharmacare.

行動與倡議

閱讀原文引述

我們正積極倡議修訂或廢除Nota 99【Nota 99是意大利藥品管理局（AIFA）針對慢性阻塞性肺病（COPD）維持療法的報銷指引，規範吸入器的處方，透過肺活量測定確保適當診斷，同時詳細說明全科醫生可啟動或重複使用的治療方案】。我們亦正積極倡議接種呼吸道合胞病毒（RSV）疫苗。

Ci stiamo battendo per la modifica/abolizione della nota 99. Ci stiamo battendo per la vaccinazione per VRS.

行動與倡議

閱讀原文引述

…與英國國會議員合作，推動更廣泛認識肺纖維化，爭取更多疾病治療資金，以及為患者及其家屬、照顧者和朋友提供更全面的支援。

Work in conjunction with national and international organisations and charities. Work with government members of parliament campaigning for better recognition of pulmonary fibrosis, additional funding for the treatment of the disease, greater support for the patients with the disease along with their families, carers and friends.